SCHEMBL2312153

SCHEMBL2312153

OC1c2ccccc2-c2c(-c3nc4ccncc4[nH]3)cccc21

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 0.64
PDE5A O76074 3/20 0.53
METAP1 P53582 2/20 0.48
METAP2 P50579 1/20 0.48
ADORA3 P0DMS8 1/20 0.46
ALDH1A1 P00352 2/20 0.43
PKM P14618 2/20 0.43
KDM4E B2RXH2 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
FGFR1 P11362 1/20 0.43
FLT1 P17948 1/20 0.43
F7 P08709 1/20 0.41
HPSE Q9Y251 1/20 0.41
AURKA O14965 1/20 0.40
RPS6KA5 O75582 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310388 1.00 HSP90AB1 (0.64) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL12431147 0.90 HSP90AB1 (0.53) HSP90AB1PDE5AMETAP1METAP2ALDH1A1
SCHEMBL2311652 0.85 HSP90AB1 (0.61) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL2311685 0.85 HSP90AB1 (0.61) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL3561942 0.83 HSP90AB1 (0.65) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL3561945 0.83 HSP90AB1 (0.65) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL2311645 0.82 HSP90AB1 (0.65) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL27716042 0.82 HSP90AB1 (0.58) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL2312611 0.82 HSP90AB1 (0.65) HSP90AB1PDE5AMETAP1METAP2ADORA3
SCHEMBL27715988 0.82 HSP90AB1 (0.60) HSP90AB1PDE5AMETAP1METAP2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101203518-B Fluorene derivative, composition containing the same and use thereof AVENTIS PHARMA SA 2013-07-24 CN disclosed
EP-1888579-B1 NOVEL FLUORENE DERIVATIVES, COMPOSITION CONTAINING SAID DERIVATIVES AND THE USE THEREOF AVENTIS PHARMA SA (FR) 2011-08-03 EP disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
CN-101203518-A Novel fluorene derivatives, compositions containing same and uses thereof AVENTIS PHARMA SA (FR) 2008-06-18 CN disclosed
EP-1888579-A2 NOVEL FLUORENE DERIVATIVES, COMPOSITION CONTAINING SAID DERIVATIVES AND THE USE THEREOF Aventis Pharma S.A. (FR) 2008-02-20 EP disclosed
WO-2006123061-A2 FLUORENE DERIVATIVES, COMPOSITION CONTAINING SAID DERIVATIVES AND THE USE THEREOF AVENTIS PHARMA S.A. (FR) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885PDE5A 2779/4885METAP1 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.